arenaviru
viru
junv
etiolog
agent
argentin
hemorrhag
fever
abl
activ
serinethreoninespecif
protein
kinas
b
pkb
also
known
akt
mean
phosphatidylinositol
pathway
viru
entri
earli
activ
play
import
role
junv
uptak
might
eventu
activ
differ
signal
pathway
contribut
cell
surviv
subsequ
viru
replic
one
target
akt
activ
eukaryot
initi
factor
bind
protein
phosphoryl
state
releas
allow
capdepend
translat
howev
case
junv
seem
dispens
translat
viral
protein
suggest
pathway
relev
function
hand
demonstr
mani
virus
abl
modul
pathway
either
activ
inhibit
order
facilit
viral
replic
activ
akt
report
associ
blockag
apoptosi
lead
longterm
cellular
surviv
allow
viru
replic
viral
protein
synthesi
case
oncogen
transform
describ
polyomavirus
human
papillomavirus
similarli
sar
coronaviru
sarscov
induc
weak
activ
akt
strong
enough
impair
apoptosi
respons
infect
nevertheless
crucial
establish
persist
contrast
earli
activ
akt
respiratori
syncyti
viru
porcin
circoviru
type
dengu
viru
denv
influenza
viru
enough
prevent
infect
cell
earli
apoptot
cell
death
work
extend
studi
particip
junv
replic
emphas
relev
akt
establish
mainten
persist
junv
infect
vero
cell
data
publish
recent
demonstr
vitro
junv
infect
lead
apoptot
cell
death
therefor
analyz
cell
surviv
cultur
infect
junv
order
evalu
activ
viru
entri
suffici
trigger
antiapoptot
respons
favor
viru
replic
purpos
vero
cell
mock
infect
infect
junv
differ
time
postinfect
pi
cell
viabil
measur
use
mtt
assay
nuclear
fragment
associ
chromatin
condens
apoptot
marker
analyz
hoechst
techniqu
briefli
cell
cultur
grown
coverslip
fix
methanol
min
methanol
discard
cultur
dri
room
temperatur
cell
stain
hoechst
min
observ
fluoresc
microscopi
shown
fig
number
apoptot
cell
could
observ
mockinfect
cultur
neglig
dark
grey
bar
proport
apoptot
cell
light
grey
bar
detect
infect
cultur
modest
viabil
junvinfect
cell
fig
light
grey
bar
remain
practic
unchang
throughout
experi
compar
valu
obtain
h
pi
wherea
mockinfect
cell
fig
dark
grey
bar
grew
steadili
time
detect
apoptot
cell
coincid
appear
distinct
cytopath
effect
cpe
character
cell
round
detach
could
readili
observ
third
day
pi
onward
data
shown
next
approach
evalu
particip
pathway
modul
apoptot
state
infect
cell
purpos
cellular
viabil
apoptosi
examin
junvinfect
cell
presenc
inhibitor
h
pi
shown
fig
treatment
induc
similar
dosedepend
reduct
cell
growth
mock
junvinfect
cell
time
junvinfect
cell
treat
show
larger
number
apoptot
cell
uninfect
treat
control
fig
howev
increas
apoptosi
normal
correspond
untreat
control
percentag
valu
similar
mock
junvinfect
cultur
fig
view
result
may
conclud
increas
number
apoptot
cell
junvinfect
cultur
treat
drug
might
due
addit
effect
viru
test
hypothesi
perform
similar
experi
dengu
viru
serotyp
viru
posit
modul
pathway
order
delay
apoptot
respons
shown
fig
inhibit
vero
cell
infect
denv
result
larg
increas
number
apoptot
cell
compar
mockinfect
control
base
result
activ
trigger
junv
entri
appear
key
factor
contribut
modul
apoptot
process
infect
cell
suggest
junv
abl
counteract
apoptosi
via
upregul
pathway
confirm
cell
treat
staurosporin
st
multifactori
strong
apoptosi
induc
proport
cell
show
chromatin
condens
nuclear
fragment
markedli
higher
infect
cell
mockinfect
cultur
fig
arenavirus
abl
establish
persist
infect
vivo
natur
host
well
vitro
sever
type
cell
cultur
persist
vivo
primarili
govern
suppress
immun
respons
persist
depend
longterm
infect
fibroblast
reticular
cell
primari
site
viru
replic
viral
target
fibroblast
reticular
cell
contribut
immunosuppress
main
effector
suppress
thu
look
longterm
infect
fibroblast
cell
line
ie
vero
cell
biolog
relev
approach
understand
vivo
persist
view
result
describ
although
junv
modul
apoptosi
via
appear
relev
surviv
infect
cultur
might
necessari
establish
persist
vitro
thu
next
goal
investig
particip
pathway
establish
persist
junv
infect
vero
cell
end
junv
infect
initi
absenc
presenc
cell
infect
junv
moi
pfucel
treat
first
second
third
fourth
week
pi
left
untreat
progress
infect
monitor
measur
express
junv
nucleoprotein
n
product
infecti
virus
cultur
abl
recov
cpe
observ
acut
stage
infect
day
pi
becam
morpholog
indistinguish
uninfect
vero
cell
data
shown
shown
fig
treatment
infect
cell
alter
pattern
express
n
cours
infect
contrast
untreat
cultur
protein
steadili
synthes
throughout
experi
inhibit
viru
replic
may
ascrib
effect
drug
adsorptionintern
step
condit
infect
low
moi
express
n
result
multistep
growth
adsorptionintern
progeni
viru
produc
cycl
hamper
drug
hand
treatment
inhibitor
abl
abolish
product
infect
although
infect
level
supernat
higher
cultur
treat
first
second
third
week
pi
fig
tempt
specul
inhibit
would
hamper
viru
replic
thu
delay
establish
persist
howev
rule
higher
titer
detect
treat
cultur
result
cyclic
product
infect
typic
earli
stage
persist
shown
fig
day
pi
cultur
synthes
n
protein
conserv
capac
produc
infecti
viru
fig
fact
indirect
immunofluoresc
assay
ifa
confirm
similar
pattern
express
n
well
main
envelop
glycoprotein
cultur
fig
character
continu
day
pi
time
persist
junvinfect
vero
cell
name
becam
nonvirogen
although
continu
express
high
level
n
note
infect
level
day
pi
higher
treat
cultur
wherea
day
pi
treat
cultur
show
low
level
infect
similar
untreat
control
suggest
treatment
effect
third
week
infect
time
point
gener
accept
transit
acut
persist
junv
infect
vero
cell
day
pi
cultur
express
high
amount
n
shown
western
blot
wb
fig
ifa
fig
howev
expect
infect
could
recov
agreement
observ
express
detect
data
shown
howev
cultur
show
capac
form
syncytia
upon
acidif
fig
describ
previous
akt
activ
propos
contribut
establish
persist
infect
dna
virus
murin
gammaherpesviru
human
herpesviru
sarcomaassoci
herpesviru
well
rna
viru
sindbi
viru
virus
persist
infect
promot
neg
regul
lytic
infect
exert
activ
akt
result
indic
inhibit
akt
would
impair
establish
persist
junv
infect
vero
cell
cultur
treat
evolv
toward
persist
fashion
similar
observ
untreat
cultur
final
investig
whether
pathway
need
mainten
persist
purpos
evalu
effect
treatment
viabil
cell
cell
treat
h
posttreat
cell
viabil
cell
morpholog
evalu
mtt
assay
phase
contrast
microscopi
respect
shown
fig
treatment
significantli
reduc
viabil
alter
morpholog
cell
wherea
vero
cell
show
reduc
surviv
alter
morpholog
compar
untreat
control
suggest
persist
cell
resist
treatment
drug
also
evalu
effect
treatment
junv
protein
synthesi
cell
end
cell
treat
process
wb
control
acut
infect
cell
vero
cell
infect
junv
moi
pfucel
adsorpt
cell
treat
drug
shown
fig
alter
synthesi
n
observ
cell
treat
either
concentr
acut
infect
cell
show
dosedepend
reduct
synthesi
viral
protein
fig
accord
previous
report
data
moreov
overexpress
domin
neg
plasmid
akt
significantli
alter
express
n
cell
analyz
ifa
fact
inhibit
observ
cell
transfect
domin
neg
plasmid
wherea
inhibit
observ
vero
cell
transfect
acut
infect
junv
result
support
conclus
activ
akt
would
relev
event
cell
even
effici
intern
viru
view
nonvirogen
phenotyp
order
determin
function
akt
persist
junvinfect
cell
initi
evalu
uptak
transferrin
tf
ligand
depend
pathway
effici
recycl
receptor
cell
incub
tritclabel
tf
min
presenc
absenc
observ
ultraviolet
microscopi
expect
vero
cell
show
characterist
accumul
label
tf
around
nucleu
observ
min
addit
tf
fig
left
column
accumul
also
observ
cell
although
level
tf
lower
fig
middl
column
moreov
treatment
cell
induc
scatter
pattern
tf
cytoplasm
indic
tf
uptak
effici
block
inhibit
fig
right
column
take
account
junv
enter
cell
use
tf
receptor
attempt
determin
superinfect
junv
abl
induc
activ
akt
phosphoryl
cell
serumstarv
cell
superinfect
junv
moi
pfucel
mock
infect
differ
time
postsuperinfect
cell
process
wb
shown
fig
junv
superinfect
induc
biphas
phosphoryl
akt
peak
min
postviruscel
contact
mocksuperinfect
cell
show
neglig
level
activ
activ
similar
biphas
activ
report
acut
infect
vero
cell
viru
furthermor
akt
phosphoryl
induc
junv
cell
suscept
inhibit
fig
lane
vs
fashion
similar
observ
junv
infect
vero
cell
fig
lane
vs
lane
likewis
treatment
also
reduc
akt
activ
induc
insulin
vero
fig
lane
vs
lane
cell
fig
lane
vs
lane
togeth
result
suggest
pathway
function
cell
involv
mainten
longterm
persist
work
extend
studi
modul
signal
pathway
junv
infect
found
modul
pathway
would
influenc
apoptot
respons
infect
take
account
low
level
apoptot
cell
junvinfect
cultur
increas
inhibit
surviv
pathway
similar
situat
describ
sarscov
activ
akt
viru
strong
enough
prevent
viral
induct
apoptosi
strong
enough
promot
establish
persist
infect
case
inhibit
pathway
unabl
impair
establish
persist
infect
junv
vero
cell
also
pathway
would
crucial
mainten
junv
persist
treatment
cell
neither
reduc
cell
viabil
impair
viral
protein
synthesi
case
measl
viru
downregul
pathway
exert
viru
suggest
strategi
interfer
tcell
activ
immunosuppress
downregul
akt
either
reduc
express
inhibit
phosphoryl
observ
junv
persist
fact
phosphoryl
akt
could
readili
observ
cell
superinfect
junv
stimul
insulin
recent
find
point
particip
rafmekerk
cellular
surviv
pathway
junv
replic
acut
stage
infect
vero
cell
tempt
postul
key
role
pathway
persist
collect
result
suggest
signal
pathway
would
play
critic
role
establishmentmainten
junv
persist
vero
cell
